Amit A Kulkarni - Projects and Grants - Experts@Minnesota

View Scopus Profile

Research activity per year

3 Finished
5 Active

5 results

Filter

Active
A Phase 1, Open-label Study of Oral BDTX-4933 in Patients with KRAS, BRAF and Other Select RAS/MAPK Mutation Positive Neoplasms
Kulkarni, A. A. (PI)
BLACK DIAMOND THERAPEUTICS, INC
11/28/23 → 11/30/33
Project: Research project
A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399)Versus Docetaxel in Subjects with Previously Treated c-Met Overexpressing, EGFR Wildtype, LocallyAdvanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
Kulkarni, A. A. (PI)
ABBVIE INC
11/6/23 → 8/7/25
Project: Research project
An Open-Label, Multi-Drug, Biomarker-Directed, Multi-Centre Phase II Umbrella Study in Patients with Non-Small Cell Lung Cancer, whoProgressed on an anti-PD-1/PD-L1 Containing Therapy (HUDSON)
Kulkarni, A. A. (PI)
ASTRAZENECA
4/1/21 → 3/26/26
Project: Research project
A randomized phase II trial of adjuvant Pembrolizumab versus observation following curative resection forstage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer ResearchConsortium BTCRC-LUN18-153
Kulkarni, A. A. (PI)
BIG TEN CANCER RESEARCH CONSORTIUM
6/29/20 → 6/30/26
Project: Research project
A Phase II Trial of Restorative Microbiota Therapy (RMT) in Combination with Durvalumab (MEDI4736) orDurvalumab (MEDI4736) + Chemotherapy in Untreated Patients with Advanced or MetastaticAdenocarcinoma Non-Small Cell Lung Cancer
Kulkarni, A. A. (PI)
ASTRAZENECA
9/16/19 → 9/30/25
Project: Research project